Latest in SABCS San Antonio Collection

Join us for continued coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 2. San Antonio Breast Cancer Symposium attendees this week considered evidence that bevacizumab plus chemotherapy may be an effective new option for the treatment of early breast cancer, in a study entitled:...

Join us for continued coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 3. Today at the San Antonio Breast Cancer Symposium, real world economics shared the stage with basic science when attendees learned that high insurance co-pays are limiting therapy for patients, in a study...

Join us for continued coverage of the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, Day 3. Participants in the San Antonio Breast Cancer Symposium today heard evidence that exemestane may be an effective alternative to anastrozole in adjuvant aromatase inhibitor therapy for early breast cancer, in a...